Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.38 | N/A | +3.31% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.38 | N/A | +3.31% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties faced in the current market but emphasized their commitment to long-term growth strategies. They highlighted ongoing investments in technology as a key focus.
We are focused on long-term growth despite current challenges.
Our investments in technology will position us well for the future.
Teladoc's earnings report shows a small EPS beat, but the lack of revenue data and no guidance updates may have contributed to the stock's decline. Investors may be cautious due to the uncertainties highlighted by management. The stock reaction reflects a market that is weighing the company's current challenges against its long-term growth potential.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMKOR TECHNOLOGY INC
Aug 1, 2016